Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hookipa Biotech initiates first-in-human study of HB-101 vaccine for CMV

June 29, 2016

Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections

June 28, 2016

European Commission approves Zavicefta for serious bacterial infections

June 28, 2016

Carbavance meets primary endpoints in phase III TANGO 1 study in patients with cUTI

June 28, 2016

Shanghai Sun-Sail Pharmaceutical Science & Technology describes antituberculosis compounds

June 28, 2016

FDA places clinical hold on Regulus' IND for RG-101 for chronic HCV infection

June 28, 2016

Regulatory dossier for Sanofi Pasteur's VaxigripTetra approved in Europe

June 27, 2016

Genticel reports 18-month data from phase II trial of HPV immunotherapeutic candidate

June 27, 2016

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016

New Pharma Licence Holdings develops antibacterial agents

June 27, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...